Status:
COMPLETED
MK0524B Bioequivalence Study (0524B-070)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Dyslipidemia
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
This study will evaluate: 1. the bioequivalence of simvastatin and simvastatin acid following dose of simvastatin (ZOCOR™) given together with one tablet of MK0524A or as a component of the triple co...
Eligibility Criteria
Inclusion
- Subject is in good health
- Subject is a nonsmoker
- Subject is willing to follow the study guidelines
Exclusion
- Subject has or has a history of any illness that might confound the results of the study or make participation in the study unsafe for the subject
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT00943124
Start Date
July 1 2007
End Date
August 1 2007
Last Update
June 19 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.